Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 503

1.

Plasma renin levels are associated with cardiac function in primary adrenal insufficiency.

Wolf P, Beiglböck H, Fellinger P, Pfleger L, Aschauer S, Gessl A, Marculescu R, Trattnig S, Kautzky-Willer A, Luger A, Winhofer Y, Krššák M, Krebs M.

Endocrine. 2019 Jun 8. doi: 10.1007/s12020-019-01974-1. [Epub ahead of print]

PMID:
31177424
2.

Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency.

Wolf P, Mayr J, Beiglböck H, Fellinger P, Winhofer Y, Poglitsch M, Gessl A, Kautzky-Willer A, Luger A, Krebs M.

Eur J Endocrinol. 2019 Jul 1;181(1):39-44. doi: 10.1530/EJE-19-0086.

PMID:
31075757
3.

Pituitary Disease in Pregnancy: Special Aspects of Diagnosis and Treatment?

Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G.

Geburtshilfe Frauenheilkd. 2019 Apr;79(4):365-374. doi: 10.1055/a-0794-7587. Epub 2019 Mar 6.

4.

[Other specific types of diabetes and exocrine pancreatic insufficiency (Update 2019)].

Kaser S, Winhofer-Stöckl Y, Kazemi-Shirazi L, Hofer SE, Brath H, Sourij H, Vila G, Abrahamian H, Riedl M, Weitgasser R, Resl M, Clodi M, Luger A.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):16-26. doi: 10.1007/s00508-019-1454-0. German.

PMID:
30980164
5.

[Treatment of acute diabetic metabolic crises in adults (Update 2019) : Hyperglycemic hyperosmolar state and ketoacidotic metabolic disorders].

Kaser S, Sourij H, Clodi M, Schneeweiß B, Laggner AN, Luger A.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):196-199. doi: 10.1007/s00508-018-1423-z. German.

PMID:
30980160
6.

[Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].

Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Lechleitner M, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):27-38. doi: 10.1007/s00508-019-1471-z. German.

PMID:
30980148
7.

[Insulin therapy of type 2 diabetes mellitus (Update 2019)].

Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S.

Wien Klin Wochenschr. 2019 May;131(Suppl 1):39-46. doi: 10.1007/s00508-019-1492-7. German.

PMID:
30980147
8.

MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.

Winhofer Y, Wolf P, Fellinger P, Tura A, Hillebrand P, Staufer K, Trauner M, Jaksch P, Muraközy G, Kautzky-Willer A, Pacini G, Krebs M, Luger A, Kazemi-Shirazi L.

Endocr Pract. 2019 Mar;25(3):254-262. doi: 10.4158/EP-2018-0461.

PMID:
30913015
9.

Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus.

Wolf P, Fellinger P, Pfleger L, Smajis S, Beiglböck H, Gajdošík M, Anderwald CH, Trattnig S, Luger A, Winhofer Y, Krššák M, Krebs M.

Sci Rep. 2019 Feb 22;9(1):2576. doi: 10.1038/s41598-019-39362-4.

10.

The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma.

Foltyn M, Luger AL, Lorenz NI, Sauer B, Mittelbronn M, Harter PN, Steinbach JP, Ronellenfitsch MW.

Br J Cancer. 2019 Mar;120(5):481-487. doi: 10.1038/s41416-018-0368-3. Epub 2019 Feb 12.

PMID:
30745581
11.

GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism.

Schernthaner-Reiter MH, Itariu BK, Krebs M, Promintzer-Schifferl M, Stulnig TM, Tura A, Anderwald CH, Clodi M, Ludvik B, Pacini G, Luger A, Vila G.

Nutr Metab Cardiovasc Dis. 2019 Apr;29(4):334-342. doi: 10.1016/j.numecd.2018.12.008. Epub 2019 Jan 3.

PMID:
30718144
12.

Correction to: Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.

Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P, Knosp E, Luger A, Vila G.

Endocrine. 2019 Apr;64(1):202. doi: 10.1007/s12020-019-01839-7.

PMID:
30680542
13.

Overweight and obesity in type 1 diabetes equal those of the general population.

Fellinger P, Fuchs D, Wolf P, Heinze G, Luger A, Krebs M, Winhofer Y.

Wien Klin Wochenschr. 2019 Feb;131(3-4):55-60. doi: 10.1007/s00508-018-1434-9. Epub 2019 Jan 7.

14.

Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells.

Bruns I, Sauer B, Burger MC, Eriksson J, Hofmann U, Braun Y, Harter PN, Luger AL, Ronellenfitsch MW, Steinbach JP, Rieger J.

J Biol Chem. 2019 Mar 1;294(9):3037-3050. doi: 10.1074/jbc.RA118.006993. Epub 2018 Dec 21.

PMID:
30578297
15.

Visibility of MRI prostate lesions on B-mode transrectal ultrasound.

Steinkohl F, Luger AK, Pichler R, Bektic J, Rehder P, Lebovici A, Aigner F.

Med Ultrason. 2018 Dec 8;20(4):441-445. doi: 10.11152/mu-1602.

16.

Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission.

Schernthaner-Reiter MH, Siess C, Gessl A, Scheuba C, Wolfsberger S, Riss P, Knosp E, Luger A, Vila G.

Endocrine. 2019 Apr;64(1):157-168. doi: 10.1007/s12020-018-1819-6. Epub 2018 Nov 22. Erratum in: Endocrine. 2019 Jan 24;:.

17.

Life Under Hypoxia Lowers Blood Glucose Independently of Effects on Appetite and Body Weight in Mice.

Abu Eid S, Hackl MT, Kaplanian M, Winter MP, Kaltenecker D, Moriggl R, Luger A, Scherer T, Fürnsinn C.

Front Endocrinol (Lausanne). 2018 Aug 28;9:490. doi: 10.3389/fendo.2018.00490. eCollection 2018.

18.

Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet.

Voss M, Lorenz NI, Luger AL, Steinbach JP, Rieger J, Ronellenfitsch MW.

Int J Mol Sci. 2018 Aug 20;19(8). pii: E2462. doi: 10.3390/ijms19082462.

19.

Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM-A Prospective Cohort Study.

Bozkurt L, Göbl CS, Baumgartner-Parzer S, Luger A, Pacini G, Kautzky-Willer A.

Int J Endocrinol. 2018 Jul 15;2018:5463762. doi: 10.1155/2018/5463762. eCollection 2018.

20.

A Consensus Statement on acromegaly therapeutic outcomes.

Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A.

Nat Rev Endocrinol. 2018 Sep;14(9):552-561. doi: 10.1038/s41574-018-0058-5. Review.

PMID:
30050156
21.

Gene Suppression of Transketolase-Like Protein 1 (TKTL1) Sensitizes Glioma Cells to Hypoxia and Ionizing Radiation.

Heller S, Maurer GD, Wanka C, Hofmann U, Luger AL, Bruns I, Steinbach JP, Rieger J.

Int J Mol Sci. 2018 Jul 25;19(8). pii: E2168. doi: 10.3390/ijms19082168.

22.

Management of Pregnant Women after Bariatric Surgery.

Harreiter J, Schindler K, Bancher-Todesca D, Göbl C, Langer F, Prager G, Gessl A, Leutner M, Ludvik B, Luger A, Kautzky-Willer A, Krebs M.

J Obes. 2018 Jun 3;2018:4587064. doi: 10.1155/2018/4587064. eCollection 2018. Review.

23.

Subependymomas - Characteristics of a "Leave me Alone" Lesion.

Kammerer S, Mueller-Eschner M, Lauer A, Luger AL, Quick-Weller J, Franz K, Harter P, Berkefeld J, Wagner M.

Rofo. 2018 Oct;190(10):955-966. doi: 10.1055/a-0576-1028. Epub 2018 Jun 18. English, German.

24.

Macimorelin as a Diagnostic Test for Adult GH Deficiency.

Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, Chanson P, Medic-Stojanoska M, Schopohl J, Zakrzewska A, Pekic S, Bolanowski M, Swerdloff R, Wang C, Blevins T, Marcelli M, Ammer N, Sachse R, Yuen KCJ.

J Clin Endocrinol Metab. 2018 Aug 1;103(8):3083-3093. doi: 10.1210/jc.2018-00665.

PMID:
29860473
25.

Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems.

Luger AL, Sauer B, Lorenz NI, Engel AL, Braun Y, Voss M, Harter PN, Steinbach JP, Ronellenfitsch MW.

Int J Mol Sci. 2018 May 17;19(5). pii: E1504. doi: 10.3390/ijms19051504.

26.

The prevalence of the metabolic syndrome and associated cardiovascular complications in adult-onset GHD during GH replacement: a KIMS analysis.

Verhelst J, Mattsson AF, Camacho-Hübner C, Luger A, Abs R.

Endocr Connect. 2018 May;7(5):653-662. doi: 10.1530/EC-18-0096. Epub 2018 Apr 16.

27.

Löfgren syndrome as secondary autoimmune disease in a patient with B-cell depletion following rituximab treatment.

Kronbichler A, Luger AK, Loacker L, Pizzini A, Löffler-Ragg J, Peschel I.

Clin Exp Rheumatol. 2018 May-Jun;36(3):515-516. Epub 2018 Mar 21. No abstract available.

PMID:
29600945
28.

Growth hormone deficiency and pregnancy: any role for substitution?

Vila G, Luger A.

Minerva Endocrinol. 2018 Dec;43(4):451-457. doi: 10.23736/S0391-1977.18.02834-1. Epub 2018 Mar 8. Review.

PMID:
29521487
29.

Out of the pot and into the fire: Explaining the vulnerability of an endangered small headwater stream fish to black-bass Micropterus spp. invasion.

Ellender BR, Weyl OLF, Alexander ME, Luger AM, Nagelkerke LAJ, Woodford DJ.

J Fish Biol. 2018 Apr;92(4):1035-1050. doi: 10.1111/jfb.13562. Epub 2018 Feb 26.

PMID:
29479690
30.

Incidental finding of an absent left common carotid artery.

Noflatscher M, Luger AK, Frank R, Glodny B, Gruber J, Marschang P.

Vasa. 2018 Feb;47(2):153-155. doi: 10.1024/0301-1526/a000680. Epub 2017 Dec 22.

31.

New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.

Krzyzanowska-Mittermayer K, Mattsson AF, Maiter D, Feldt-Rasmussen U, Camacho-Hübner C, Luger A, Abs R.

J Clin Endocrinol Metab. 2018 Feb 1;103(2):523-531. doi: 10.1210/jc.2017-01899.

PMID:
29228199
32.

[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities].

Petersenn S, Christ-Crain M, Droste M, Finke R, Flitsch J, Kreitschmann-Andermahr I, Luger A, Schopohl J, Stalla G.

Internist (Berl). 2017 Nov;58(11):1171-1182. doi: 10.1007/s00108-017-0331-z. Review. German.

PMID:
29027568
33.

Diagnostic hierarchy of radiological features in soft tissue tumours and proposition of a simple diagnostic algorithm to estimate malignant potential of an unknown mass.

Gruber L, Gruber H, Luger AK, Glodny B, Henninger B, Loizides A.

Eur J Radiol. 2017 Oct;95:102-110. doi: 10.1016/j.ejrad.2017.07.020. Epub 2017 Jul 28.

PMID:
28987653
34.

Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly.

van der Lely AJ, Gomez R, Pleil A, Badia X, Brue T, Buchfelder M, Burman P, Clemmons D, Ghigo E, Jørgensen JOL, Luger A, van der Lans-Bussemaker J, Webb SM, Strasburger CJ.

Pituitary. 2017 Dec;20(6):692-701. doi: 10.1007/s11102-017-0835-5.

35.

Prognostic factors in endovascular treated pelvic haemorrhage after blunt trauma.

Rehwald R, Schönherr E, Petersen J, Jeske HC, Fialkovska A, Luger AK, Grams AE, Loizides A, Jaschke W, Glodny B.

BMC Surg. 2017 Aug 9;17(1):89. doi: 10.1186/s12893-017-0283-1.

36.

[Ultrasonography of the prostate gland : From B‑image through multiparametric ultrasound to targeted biopsy].

Steinkohl F, Luger A, Bektic J, Aigner F.

Radiologe. 2017 Aug;57(8):615-620. doi: 10.1007/s00117-017-0274-3. Review. German.

PMID:
28702693
37.

PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex.

Kiefer FW, Winhofer Y, Iacovazzo D, Korbonits M, Wolfsberger S, Knosp E, Trautinger F, Höftberger R, Krebs M, Luger A, Gessl A.

Eur J Endocrinol. 2017 Aug;177(2):K7-K12. doi: 10.1530/EJE-17-0227. Epub 2017 May 18.

PMID:
28522647
38.

Genetics of Diabetes Insipidus.

Schernthaner-Reiter MH, Stratakis CA, Luger A.

Endocrinol Metab Clin North Am. 2017 Jun;46(2):305-334. doi: 10.1016/j.ecl.2017.01.002. Epub 2017 Feb 28. Review.

PMID:
28476225
39.

Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients.

Harreiter J, Kosi-Trebotic L, Lukas A, Wolf P, Winhofer Y, Luger A, Kautzky-Willer A, Krebs MR.

Diabetes Ther. 2017 Jun;8(3):683-692. doi: 10.1007/s13300-017-0249-4. Epub 2017 Mar 29.

40.

Hypothyroidism and Hyponatremia: Rather Coincidence Than Causality.

Wolf P, Beiglböck H, Smaijs S, Wrba T, Rasoul-Rockenschaub S, Marculescu R, Gessl A, Luger A, Winhofer Y, Krebs M.

Thyroid. 2017 May;27(5):611-615. doi: 10.1089/thy.2016.0597. Epub 2017 Apr 19.

PMID:
28351291
41.

Chronic Intranasal Insulin Does Not Affect Hepatic Lipids but Lowers Circulating BCAAs in Healthy Male Subjects.

Scherer T, Wolf P, Smajis S, Gaggini M, Hackl M, Gastaldelli A, Klimek P, Einwallner E, Marculescu R, Luger A, Fürnsinn C, Trattnig S, Buettner C, Krššák M, Krebs M.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1325-1332. doi: 10.1210/jc.2016-3623.

42.

Preclinical characterization of 55P0251, a novel compound that amplifies glucose-stimulated insulin secretion and counteracts hyperglycaemia in rodents.

Stadlbauer K, Brunmair B, Lehner Z, Adorjan I, Scherer T, Luger A, Bauer L, Fürnsinn C.

Diabetes Obes Metab. 2017 Aug;19(8):1088-1096. doi: 10.1111/dom.12914. Epub 2017 Apr 3.

PMID:
28211608
43.

Men's sexual response to female partner's intranasal oxytocin administration for hypoactive sexual desire disorder: an open prospective cohort study.

Muin DA, Sheikh Rezaei S, Tremmel-Scheinost M, Salama M, Luger A, Wolzt M, Husslein PW, Bayerle-Eder M.

Fertil Steril. 2017 Mar;107(3):781-787.e3. doi: 10.1016/j.fertnstert.2016.12.003. Epub 2017 Feb 8.

PMID:
28189292
44.

Emodin, a compound with putative antidiabetic potential, deteriorates glucose tolerance in rodents.

Abu Eid S, Adams M, Scherer T, Torres-Gómez H, Hackl MT, Kaplanian M, Riedl R, Luger A, Fürnsinn C.

Eur J Pharmacol. 2017 Mar 5;798:77-84. doi: 10.1016/j.ejphar.2017.01.022. Epub 2017 Jan 18.

PMID:
28108376
45.

B-type natriuretic peptide increases cortisol and catecholamine concentrations in healthy subjects.

Grimm G, Resl M, Heinisch BB, Hülsmann M, Luger A, Clodi M, Vila G.

J Appl Physiol (1985). 2017 May 1;122(5):1249-1254. doi: 10.1152/japplphysiol.00360.2016. Epub 2016 Dec 22.

46.

Soft-Tissue Tumor Contrast Enhancement Patterns: Diagnostic Value and Comparison Between Ultrasound and MRI.

Gruber L, Loizides A, Luger AK, Glodny B, Moser P, Henninger B, Gruber H.

AJR Am J Roentgenol. 2017 Feb;208(2):393-401. doi: 10.2214/AJR.16.16859. Epub 2016 Dec 13.

PMID:
27959625
47.

Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.

Schernthaner-Reiter MH, Kasses D, Tugendsam C, Riedl M, Peric S, Prager G, Krebs M, Promintzer-Schifferl M, Clodi M, Luger A, Vila G.

Eur J Endocrinol. 2016 Dec;175(6):623-631.

PMID:
27926473
48.

Bridging the gap: metabolic and endocrine care of patients during transition.

Hokken-Koelega A, van der Lely AJ, Hauffa B, Häusler G, Johannsson G, Maghnie M, Argente J, DeSchepper J, Gleeson H, Gregory JW, Höybye C, Keleştimur F, Luger A, Müller HL, Neggers S, Popovic-Brkic V, Porcu E, Sävendahl L, Shalet S, Spiliotis B, Tauber M.

Endocr Connect. 2016 Nov;5(6):R44-R54. Epub 2016 Nov 1. Review.

49.

GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes.

Pavo N, Wurm R, Neuhold S, Adlbrecht C, Vila G, Strunk G, Clodi M, Resl M, Brath H, Prager R, Luger A, Pacher R, Hülsmann M.

Clin Chem. 2016 Dec;62(12):1612-1620. Epub 2016 Oct 18.

50.

Hyperglycemia in pasireotide-treated patients with acromegaly and its treatment.

Luger A.

Endocrine. 2016 Oct;54(1):1-2. Epub 2016 Jul 8. No abstract available.

PMID:
27388591

Supplemental Content

Support Center